FEB 04, 2016 10:03 AM PST

Proton Therapy Zaps More Cancer, Less Healthy Cells

WRITTEN BY: Xuan Pham
Childhood brain cancers may fare better with proton beam therapy than conventional radiotherapies, say researchers from the Massachusetts General Hospital (MGH). Their latest study was recently published in The Lancet Oncology.
 
Proton therapy for cancer has less side effects

Medulloblastoma is of the most common and deadly form of pediatric brain cancer. The malignant tumor cells rapidly grow out of control at the base of the brain, near the cerebellum. There, they aggressively metastasize through the cerebral spinal fluid to other locations on the brain and spine cord. Once the medulloblastoma spreads, the five-year survival rate drops to about 60%.
 
Though catching and treating the cancer early is generally considered a good thing, medulloblastoma treatments have so far been a double-edged sword for the pediatric patients. Once diagnosed, the children typically undergo surgeries for removal, followed by intense photon radiotherapy and chemotherapy. These treatments kill the cancer cells, but they also kill the healthy cells in the children’s fragile but rapidly growing brains. Patients often develop cognitive deficits along with other organ problems as a due to radiation exposure. As a result, earlier treatments are often associated with severe long-term side effects.
 
To reduce the collateral damages to healthy brain cells, researchers turned to proton therapy. Also known as proton beam therapy, the treatment uses the ionizing power of protons to damage the DNA of cancer cells, and thus kill them. X-rays do the same thing, but proton beams can do it in a more targeted fashion, reducing the amount of damage to healthy cells.
 
 
Led by Dr. Torunn Yock of MGH, the research team evaluated the outcome of proton therapy in children with medulloblastomas. All 59 patients had surgeries to remove the tumors, and then were subsequently treated with proton beam therapy. Patients also received chemotherapy in conjunction with the proton treatment. Researchers charted the patients’ response to the treatments over the course of 8 years.
 
Though they found that though proton therapy didn’t improve patient survival rates, the side effects were reduced. For example, at five years post treatment, 16% of patients displayed hearing loss, compared to the 25% reported in studies using conventional radiotherapy.
 
Other cognitive functions, such as verbal comprehension and processing speed, though affected, were not as deficient than that reported with photon therapy. Most significantly, the children who received proton therapy did not have any side effects in the heart, lungs, or intestines. These organs are commonly affected in traditional photon therapies.
 
The findings show that proton beam treatment is as effective as traditional methods, but is less toxic to the patients.

"I truly believe that - particularly for the youngest children - the ability to offer them proton therapy can make a big difference in their lives." – Dr. Yock, senior study author.

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 28, 2018
Clinical & Molecular DX
MAY 28, 2018
Bacterial Toxin Linked to Inflammatory Bowel Disease
Scientists have found evidence that it's not a bacterium, but one of its toxins, that is connected to, and possibly causing intestinal dysfunction....
JUN 23, 2018
Clinical & Molecular DX
JUN 23, 2018
Algorithm-Based Blood Test Diagnoses Autism
As a developmental disorder, autism spectrum disorders (ASD) can be diagnosed as early as 18 to 24 months of age, but often the diagnosis does not come unt...
JUL 13, 2018
Genetics & Genomics
JUL 13, 2018
Detecting Leukemia Before it Starts Growing
Researchers have found ways to identify people who may develop an aggressive type of blood cancer while they are still healthy....
OCT 29, 2018
Immunology
OCT 29, 2018
Escape of the Tumor Cell
Tumor cells in breast cancer have proven to evade the immune responses utilizing actin cytoskeleton...
OCT 30, 2018
Drug Discovery
OCT 30, 2018
Re-sensitizing Drug-resistant Human Tumor Cells
Understanding how cancer cells avoid death despite their DNA being damaged will create new strategies to enhance cancer cell killing through chemotherapy t...
NOV 26, 2018
Health & Medicine
NOV 26, 2018
The Role of Clinical Lab Scientists
The clinical laboratory is the heart of any hospital or healthcare system. It is responsible for greater than 70% of medical diagnoses and decisions made b...
Loading Comments...